2095158
Last Update Posted: 2019-11-18
Recruiting has ended
All Genders accepted | 18 Years + |
440 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea
This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride (HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.
Eligibility
Relevant conditions:
Erythema
Rosacea
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov